News

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon ...
All of us produce a growth factor—called IL-15—which effectively protects us from cancers. Its role is to boost the ...
To assess T-cell-induced morphological changes, each organoid was segmented in the transmitted light (TL) channel using a ...
The following is a summary of "Advances and challenges in targeted therapies for HER2-amplified colorectal cancer," published ...
A fourth revolution in cancer care is taking shape, one that steps away from the current well-trodden path. This revolution ...
OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, has selected EVERSANA®, a leading provider ...
J. Finn, Ph.D., a distinguished professor of immunology and surgery at the University of Pittsburgh School of Medicine and ...
All of us produce a growth factor – called IL-15 – which effectively protects us from cancers. It's role is to boost the ...
Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not ...
Knowable Magazine shares how studies show psychological strain can accelerate tumors and asks if beta blockers slow them down ...
We could be on the verge of a major cancer treatment breakthrough, with a new vaccine shown to completely obliterate pancreatic cancer cells in preclinical trials. This paves the way for it to move ...
EGFR inhibitors such as Erbitux and Gilotrif show potential in laboratory and mouse studies in treating melanoma with a ...